The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Confidence intervals for the number needed to treat.
Open accessAbstract
Chronic obstructive pulmonary disease has been associated with a high frequency of arrhythmias. Few studies have analysed the role of reduced lung function in predicting atrial fibrillation (AF). The aim of the present study was to investigate the relationship between forced expiratory volume in one second (FEV1) and risk of first episode of AF in a prospective study. Data from 13,430 males and females without previous myocardial infarction, who participated in the Copenhagen City Heart Study, were analysed. New AF was assessed at re-examination after 5 yrs and by hospital admission for AF during a period of 13 yrs. Multivariate analyses were used with adjustment for cardiopulmonary risk factors. There were 62 new cases of AF at 5-yr follow-up (0.58%) and 290 cases (2.20%) diagnosed at hospitalisations. Risk of new AF at re-examination was 1.8-times higher for FEV1 between 60–80% of predicted compared with FEV1 ≥80% after adjustment for sex, age, smoking, blood pressure, diabetes and body mass index. The risk of AF hospitalisation was 1.3-times higher for FEV1 between 60–80% and 1.8-times higher for FEV1 <60% compared with FEV1 ≥80%, when additional adjustment was made for education, treatment with diuretics and chest pain at activity. The authors conclude that reduced lung function is an independent predictor for incident atrial fibrillation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This yields NNTs of 6.09 (95% CI: 3.07 – ∞ – NNH 90.15) and 3.63 (95% CI: 2.23–12.29) [33] respectively.”
From Internet-Based CBT for Depression with and without Telephone Tracking in a National Helpline: Randomised Controlled Trial (2011) · cites this paper as [33]
Citations
Cites
Evidence-Based Medicine: How to Practice and Teach EBM
Sackett, D. L. (2000) · Cited by 5,950
Improving the Quality of Reporting of Randomized Controlled Trials: The CONSORT Statement
Begg, C. (1996) · JAMA · doi:10.1001/jama.1996.03540080059030 · Cited by 3,127
The number needed to treat: a clinically useful measure of treatment effect
Cook, R. J., & Sackett, D. L. (1995) · BMJ · doi:10.1136/bmj.310.6977.452 · Cited by 1,885
An Assessment of Clinically Useful Measures of the Consequences of Treatment
Laupacis, A., Sackett, D. L., & Roberts, R. S. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806303182605 · Cited by 1,681
Statistical guidelines for contributors to medical journals.
Altman, D. G., Gore, S. M., Gardner, M. J., & Pocock, S. (1983) · BMJ · doi:10.1136/bmj.286.6376.1489 · Cited by 662
Self-citationMeta-analysis of randomised trials comparing coronary angioplasty with bypass surgery
Pocock, S., Henderson, R. A., Rickards, A. F., Hampton, J. R., King, S. B., Hamm, C. W., Puel, J., Hueb, W. A., Goy, J. J., & Rodriguez, A. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92897-9 · Cited by 527
Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation
Silagy, C., Mant, D., Fowler, G., & Lodge, M. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90933-4 · Cited by 481
Using Numerical Results from Systematic Reviews in Clinical Practice
McQuay, H. J., & Moore, R. A. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-9-199705010-00007 · Cited by 452
Confidence Limits Made Easy: Interval Estimation Using a Substitution Method
Daly, L. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009523 · Cited by 289
Sackett, D. L., Deeks, J. J., & Altman, D. G. (1996) · BMJ Evidence-Based Medicine · doi:10.1136/ebm.1996.1.164 · Cited by 178
Self-citation
Research works printed but not linked: 1
- 10.1136/ebm.1.6.164 · DOI
Cited by
Sorted by citations
Items 401–500 of 938
Willems, L. H., Maas, D. P. M. S. M., Kramers, K., Reijnen, M. M. P. J., Riksen, N. P., Cate, H. T., van der Vijver-Coppen, R. J., de Borst, G. J., Mees, B., Zeebregts, C. J., et al. (2022) · Drugs · doi:10.1007/s40265-022-01756-6 · Cited by 37
Prediabetes: a must to recognise disease state
Shehab-Eldin, W. A., Emara, M., & Shoker, A. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01705.x · Cited by 33
Medical doctors' perception of the "number needed to treat" (NNT)
Halvorsen, P. A., Kristiansen, I. S., Aasland, O. G., & Førde, O. H. (2003) · Scandinavian Journal of Primary Health Care · doi:10.1080/02813430310001158 · Cited by 33
Hak, E., Wei, F., Grobbee, D. E., & Nichol, K. L. (2004) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.01.019 · Cited by 33
The number needed to treat: a useful clinical measure or a case of the Emperor's new clothes?
Grieve, A. P. (2003) · Pharmaceutical Statistics · doi:10.1002/pst.33 · Cited by 33
Efectividad de la vacuna frente al neumococo en el anciano. Revisión sistemática y metaanálisis
Puig‐Barberà, J., Belenguer‐Varea, Á., Pinto, M. G., & Benlliure, M. J. B. (2002) · Atención Primaria · doi:10.1016/s0212-6567(02)79027-6 · Cited by 33
van de Loo, M., van Kaam, A. H., Offringa, M., Doyle, L. W., Cooper, C., & Onland, W. (2024) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013271.pub2 · Cited by 32
Altitude as a Protective Factor from COVID-19
Thomson, T. M., Casas, F., Guerrero, H. A., Figueroa‐Mujíca, R., Villafuerte, F. C., & Machicado, C. (2020) · High Altitude Medicine & Biology · doi:10.1089/ham.2020.0202 · Cited by 33
Antibiotics for secondary prevention of coronary heart disease
Sethi, N. J., Safi, S., Korang, S. K., Hróbjartsson, A., Skoog, M., Gluud, C. N., & Jakobsen, J. C. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003610.pub4 · Cited by 37
A Perspective on Characterizing Benefits and Risks Derived from Clinical Trials: Can We Do More?
O’Neill, R. T. (2008) · Drug Information Journal · doi:10.1177/009286150804200305 · Cited by 33
Prospective, blind study of the triple stimulation technique in the diagnosis of ALS
Kleine, B. U., Schelhaas, H. J., van Elswijk, G., de Rijk, M. C., Stegeman, D. F., & Zwarts, M. J. (2010) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482960903171128 · Cited by 32
Evidence-based dermatology: Number needed to treat and its relation to other risk measures
Manríquez, J. J., Villouta, M. F., & Williams, H. C. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.08.024 · Cited by 32
Wallace, A. E., Neily, J. B., Weeks, W. B., & Friedman, M. J. (2006) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.16.37 · Cited by 32
Meta‐Analysis of Azelastine Nasal Spray for the Treatment of Allergic Rhinitis
Lee, T. A., & Pickard, A. S. (2007) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.6.852 · Cited by 32
Abdallah, F. W., Morgan, P. J., Cil, T. D., Escallon, J. M., Semple, J. L., & Chan, V. W. S. (2015) · Pain · doi:10.1097/j.pain.0000000000000108 · Cited by 31
Cuppone, F., Bria, E., Vaccaro, V., Puglisi, F., Fabi, A., Sperduti, I., Carlini, P., Milella, M., Nisticò, C., Russillo, M., et al. (2011) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-30-54 · Cited by 31
Recent Clinical Trials Insights into the Treatment of Primary Membranous Nephropathy
Rojas-Rivera, J. E., Fervenza, F. C., & Ortíz, A. (2021) · Drugs · doi:10.1007/s40265-021-01656-1 · Cited by 32
Estimates of clinically useful measures in competing risks survival analysis
Ambrogi, F., Biganzoli, E. M., & Boracchi, P. (2008) · Statistics in Medicine · doi:10.1002/sim.3455 · Cited by 31
Number Needed to Treat: Analyzing of the Effectiveness of Thoracoabdominal Aortic Repair
Miller, C. C., Porat, E. E., Estrera, A. L., Winnerkvist, A., Huynh, T. T., & Safi, H. J. (2004) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2004.03.004 · Cited by 31
Chang, W., Xu, N., Kumagai, T., Shiraishi, T., Kikuyama, T., Omizo, H., Sakai, K., Arai, S., Tamura, Y., Ota, T., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154469 · Cited by 30
Vallentin-Holbech, L., Rasmussen, B. M., & Stock, C. (2018) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2018.10.019 · Cited by 32
Number needed to treat: A primer for neurointerventionalists
Martínez-Gutiérrez, J. C., Leslie‐Mazwi, T. M., Chandra, R. V., Ong, K. L., Nogueira, R. G., Goyal, M., Albuquerque, F. C., & Hirsch, J. A. (2019) · Interventional Neuroradiology · doi:10.1177/1591019919858733 · Cited by 30
Boers, N., Michielsens, C. A. J., van der Heijde, D. M. F. M., den Broeder, A. A., & Welsing, P. M. J. (2019) · Lara D. Veeken · doi:10.1093/rheumatology/kez363 · Cited by 30
Murad, M. H., Montori, V. M., Walter, S. D., & Guyatt, G. H. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2008.11.005 · Cited by 30
Arrow, P., & Klobas, E. (2015) · Community Dentistry And Oral Epidemiology · doi:10.1111/cdoe.12176 · Cited by 30
Villar, J., Pérez‐Méndez, L., Aguirre‐Jaime, A., & Kacmarek, R. M. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2519-7 · Cited by 27
Using the number needed to treat in clinical practice
Weeks, D. L., & Noteboom, J. T. (2004) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2004.03.025 · Cited by 29
Improving first‐time donor attendance rates through the use of enhanced donor preparation materials
Masser, B., France, C. R., Foot, J., Rozsa, A., Hayman, J., Waller, D., & Hunder, E. (2016) · Transfusion · doi:10.1111/trf.13496 · Cited by 29
Bateman, E. D., O’Byrne, P. M., FitzGerald, J. M., Barnes, P. J., Zheng, J., Lamarca, R., Puu, M., Parikh, H., Alagappan, V., & Reddel, H. K. (2021) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202011-1386oc · Cited by 29
Systematic review of the effectiveness of population screening for colorectal cancer.
Kerr, J., Day, P. J., Broadstock, M., Weir, R., & Bidwell, S. (2007) · PubMed · Cited by 29
The Number Needed to Treat: 25 Years of Trials and Tribulations in Clinical Research
Suissa, S. (2015) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10218 · Cited by 28
Gosmann, N. P., Costa, M. D. A., Jaeger, M. D. B., Frozi, J., Spanemberg, L., Manfro, G. G., Cortese, S., Cuijpers, P., Pine, D. S., & Salum, G. A. (2023) · Psychological Medicine · doi:10.1017/s0033291723001630 · Cited by 28
Scott, J., Jones, T., Redaniel, M. T., May, M., Ben‐Shlomo, Y., & Caskey, F. J. (2019) · BMC Nephrology · doi:10.1186/s12882-019-1633-2 · Cited by 30
Use of Hyaluronidase to Prevent Perineal Trauma During Spontaneous Delivery: A Pilot Study
Scarabotto, L. B., & Riesco, M. L. G. (2008) · Journal of Midwifery & Women s Health · doi:10.1016/j.jmwh.2008.02.015 · Cited by 28
Drewes, Y. M., Poortvliet, R. K. E., Blom, J. W., de Ruijter, W., Westendorp, R. G. J., Stott, D. J., Blom, H. J., Ford, I., Sattar, N. A., Jukema, J. W., et al. (2014) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12660 · Cited by 27
Boukelia, B., Fogarty, M., Davison, R. R., & Florida-James, G. D. (2016) · European Journal of Applied Physiology · doi:10.1007/s00421-016-3489-5 · Cited by 27
Epidemiological Methods: About Time
KRAEMER, H. C. (2009) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph7010029 · Cited by 27
Issues with number needed to treat
Julious, S. A. (2005) · Statistics in Medicine · doi:10.1002/sim.2150 · Cited by 27
Nielsen, R. E., Laursen, M. F., Vernal, D. L., Bisgaard, C., Jakobsen, H. N., Steinhausen, H., & Correll, C. U. (2014) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2014.04.023 · Cited by 29
Vo, P. G., Wen, S., Martel, M.-J., Mitsikostas, D. D., Reuter, U., & Klatt, J. (2018) · Cephalalgia · doi:10.1177/0333102418801579 · Cited by 27
Thompson, S. G., Warn, D. E., & Turner, R. (2003) · Statistics in Medicine · doi:10.1002/sim.1567 · Cited by 27
Benefits and Risks of Pharmacotherapy for Dysthymia: A Systematic Appraisal of the Evidence
De Lima, M. S., & Hotopf, M. (2003) · Drug Safety · doi:10.2165/00002018-200326010-00006 · Cited by 25
Phiri, K. S., Khairallah, C., Kwambai, T. K., Bojang, K., Dhabangi, A., Opoka, R., Idro, R., Stepniewska, K., van Hensbroek, M. B., John, C. C., et al. (2023) · The Lancet Global Health · doi:10.1016/s2214-109x(23)00492-8 · Cited by 26
van den Berg, G. H., Lindeboom, R., & van der Zwet, W. C. (2014) · Clinical Nutrition · doi:10.1016/j.clnu.2014.04.011 · Cited by 26
Halpin, D. M. G. (2005) · International Journal of Clinical Practice · doi:10.1111/j.1368-5031.2005.00664.x · Cited by 26
Risk of Subsequent Primary Kidney Cancer After Another Malignancy: A Population-based Study
Abdel-Rahman, O. M. (2017) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2017.02.004 · Cited by 26
Estimating the number needed to treat (NNT) index when the data are subject to error
Walter, S. D., & Irwig, L. (2001) · Statistics in Medicine · doi:10.1002/sim.707 · Cited by 26
Sponsorship, authorship, and accountability
Wilkes, M. S. (2001) · Western Journal of Medicine · doi:10.1136/ewjm.175.4.259 · Cited by 26
Rassen, J. A., Solomon, D. H., Glynn, R. J., & Schneeweiß, S. (2011) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2121 · Cited by 25
Computing and interpreting the Number Needed to Treat for Cardiovascular Outcomes Trials
Ludwig, L., Darmon, P., & Guerci, B. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01034-3 · Cited by 25
Li, G., Lip, G. Y. H., Marcucci, M., Thabane, L., Tian, J., & Levine, M. (2020) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2020.05.031 · Cited by 25
Beyer, K. J., Taffé, P., Halfon, P., Pittet, V. E. H., Pichard, S., Haller, G., Burnand, B., & for the ADS study Group (2009) · Anaesthesia · doi:10.1111/j.1365-2044.2008.05821.x · Cited by 25
Number needed to treat for time‐to‐event data with competing risks
Gouskova, N., Kundu, S., Imrey, P. B., & Fine, J. P. (2013) · Statistics in Medicine · doi:10.1002/sim.5922 · Cited by 25
Saposnik, G., Demchuk, A. M., Tu, J. V., & Johnston, S. C. (2012) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2012.09.001 · Cited by 25
Evaluating cytology for the detection of invasive cervical cancer
Landy, R., Castañón, A., Hamilton, W. T., Lim, A. W., Dudding, N., Hollingworth, A., & Sasieni, P. D. (2015) · Cytopathology · doi:10.1111/cyt.12259 · Cited by 25
Quantitative research: Designs relevant to nursing and healthcare
Seers, K., & Critelton, N. (2001) · Journal of research in nursing · doi:10.1177/136140960100600103 · Cited by 25
Alcoholic versus aqueous chlorhexidine for skin antisepsis: the AVALANCHE trial
Charles, D., Heal, C. F., Delpachitra, M., Wohlfahrt, M., Kimber, D., Sullivan, J., Browning, S., Saednia, S., Hardy, A., Banks, J. L., et al. (2017) · Canadian Medical Association Journal · doi:10.1503/cmaj.161460 · Cited by 25
de Souza, E. A., Ferreira, A. F., Heukelbach, J., Boigny, R. N., Alencar, C. H., & Ramos, A. N. (2018) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed3030079 · Cited by 25
Numbers needed to treat (needlessly?)
Bogaty, P. M., & Brophy, J. M. (2005) · The Lancet · doi:10.1016/s0140-6736(05)61025-2 · Cited by 25
Kannisto, S., Voutilainen, R., Remes, K., & Korppi, M. O. (2002) · Pediatric Allergy and Immunology · doi:10.1034/j.1399-3038.2002.00084.x · Cited by 25
A Bayesian network meta-analysis on second-line systemic therapy in advanced gastric cancer
Zhu, X., Ko, Y., Berry, S., Shah, K. T., Lee, E., & Chan, K. (2016) · Gastric Cancer · doi:10.1007/s10120-016-0656-7 · Cited by 24
Cognitive–behavioural therapy for clozapine-resistant schizophrenia: the FOCUS RCT
Morrison, A. P., Pyle, M., Gumley, A. I., Schwannauer, M., Turkington, D., MacLennan, G., Norrie, J. D., Hudson, J., Bowe, S. E., French, P., et al. (2019) · Health Technology Assessment · doi:10.3310/hta23070 · Cited by 25
Fluoroquinolone Antibiotics and Tendon Injury in Adolescents
Ross, R. K., Kinlaw, A. C., Herzog, M. M., Funk, M. J., & Gerber, J. S. (2021) · PEDIATRICS · doi:10.1542/peds.2020-033316 · Cited by 26
Gehrmann, U., Kuß, O., Wellmann, J., & Bender, R. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.01.011 · Cited by 24
Bjertnæs, L. J., Hindberg, K., Næsheim, T., Suborov, E. V., Reierth, E., Кirov, М. Y., Лебединский, К. М., & Tveita, T. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.641633 · Cited by 25
Cuppone, F., Bria, E., Giannarelli, D., Vaccaro, V., Milella, M., Nisticò, C., Ruggeri, E. M., Sperduti, I., Sergio Bracarda, A., Pinnarò, P., et al. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-675 · Cited by 23
Safety of dimethyl fumarate for multiple sclerosis: A systematic review and meta-analysis
Liang, G., Chai, J., Ng, H. S., & Tremlett, H. L. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102566 · Cited by 23
Khasanova, D. R., & Николаевич, К. М. (2023) · BMC Neurology · doi:10.1186/s12883-023-03159-w · Cited by 23
Wong, S., Kwan, A. T. H., Teopiz, K. M., Le, G. H., Meshkat, S., Ho, R., d’Andrea, G., Cao, B., Vincenzo, J. D. D., Rosenblat, J. D., et al. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.01.142 · Cited by 24
Armstrong, A. W., Betts, K. A., Sundaram, M., Thomason, D., & Signorovitch, J. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.05.040 · Cited by 23
Mendes, D., Alves, C., & Marques, F. B. (2016) · CNS Drugs · doi:10.1007/s40263-016-0377-9 · Cited by 23
To start or not: Factors to consider when implementing routine probiotic use in the NICU
Barbian, M. E., Buckle, R. L., Denning, P. W., & Patel, R. M. (2019) · Early Human Development · doi:10.1016/j.earlhumdev.2019.05.009 · Cited by 23
Braun, L., Titzler, I., Terhorst, Y., Freund, J., Thielecke, J., Ebert, D. D., & Baumeister, H. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.09.066 · Cited by 27
Metaanalyses of Acustimulations: Effects on Nausea and Vomiting in Postoperative Adult Patients
Shiao, S.-Y. P. K., & Dune, L. S. (2006) · EXPLORE · doi:10.1016/j.explore.2006.02.005 · Cited by 23
The Use of Numbers Needed to Treat Derived from Systematic Reviews and Meta-Analysis
Ebrahim, S. B. J. (2001) · Evaluation & the Health Professions · doi:10.1177/01632780122034858 · Cited by 23
Number Needed to Treat ( NNT )
Bender, R. (2005) · Encyclopedia of Biostatistics · doi:10.1002/0470011815.b2a04032 · Cited by 23
Roehm, E. (2015) · Obstetrics and Gynecology International · doi:10.1155/2015/713295 · Cited by 22
Pierro, F. D., Sinatra, F., Cester, M., Ros, L. D., Pistolato, M., Parè, V. D., Fabbro, L., Maccari, D., Dotto, S., Sossai, S., et al. (2023) · Microorganisms · doi:10.3390/microorganisms11112796 · Cited by 21
Perry, Y., Calear, A. L., Mackinnon, A. J., Batterham, P. J., Licinio, J., KING, C. A., Thomsen, N., Scott, J. L., Donker, T., Merry, S., et al. (2015) · Trials · doi:10.1186/s13063-015-0929-1 · Cited by 26
Exaggeration of treatment benefits using the "event-based" number needed to treat
Aaron, S. D., & Fergusson, D. A. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.080018 · Cited by 22
Pharmacological Treatments of Bell's Palsy in Adults: A Systematic Review and Network Meta‐Analysis
Jalali, M. M., Soleimani, R., Soltanipour, S., & Jalali, S. M. (2021) · The Laryngoscope · doi:10.1002/lary.29368 · Cited by 22
Rice, S., Hickie, I. B., Yung, A. R., Mackinnon, A. J., Berk, M., Davey, C. G., Hermens, D. F., Hetrick, S. E., Parker, A. G., Schäfer, M. R., et al. (2014) · Early Intervention in Psychiatry · doi:10.1111/eip.12166 · Cited by 24
Impact numbers in health policy decisions
Attia, J., Page, J., Heller, R. F., & Dobson, A. J. (2002) · Journal of Epidemiology & Community Health · doi:10.1136/jech.56.8.600 · Cited by 22
Meloni, A. R., DeYoung, M. B., Han, J., Best, J. H., & Grimm, M. F. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-48 · Cited by 20
Heuts, S., Ubben, J. F. H., Kawczynski, M. J., Gabrio, A., Suverein, M. M., Delnoij, T., Kaválková, P., Rob, D., Komárek, A., van der Horst, I. C. C., et al. (2024) · Critical Care · doi:10.1186/s13054-024-05008-9 · Cited by 21
Premature Knee Osteoarthritis After Anterior Cruciate Ligament Reconstruction Dependent on Autograft
Vairo, G. L., McBrier, N. M., Miller, S. J., & Buckley, W. E. (2010) · Journal of Sport Rehabilitation · doi:10.1123/jsr.19.1.86 · Cited by 21
Faulkner, J., Stoner, L. R., Lanford, J., Jolliffe, E. A., Mitchelmore, A., & Lambrick, D. (2016) · Translational Stroke Research · doi:10.1007/s12975-016-0510-6 · Cited by 21
Shand, F., Mackinnon, A. J., O’Moore, K., Ridani, R., Reda, B., Hoy, M., Heard, T. R., Duffy, L., Shanahan, M., Pulver, L. J., et al. (2019) · Trials · doi:10.1186/s13063-019-3262-2 · Cited by 20
Andersson, T., Nåtman, J., Mourtzinis, G., Bager, J., Boström, K. B., Franzén, S., & Hjerpe, P. (2023) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwad212 · Cited by 21
Skonnord, T., Skjeie, H., Brekke, M., Klovning, A., Grotle, M., Aas, E., Mdala, I., & Fetveit, A. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-034157 · Cited by 20
Systematische Übersichtsarbeiten und Metaanalysen in der Chirurgie
Diener, M. K., Seiler, C. M., & Antes, G. (2007) · Der Chirurg · doi:10.1007/s00104-007-1404-7 · Cited by 20
Maxwell, C. J., Campitelli, M. A., Hogan, D. B., Diong, C. C., Austin, P. C., Amuah, J. E., Lapane, K. L., Seitz, D. P., Gill, S. S., Gruneir, A., et al. (2018) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4385 · Cited by 19
A Community Hospital NICU Developmental Care Partner Program
Clubbs, B. H., Barnette, A. R., Gray, N., Weiner, L., Bond, A., Harden, J., & Pineda, R. G. (2019) · Advances in Neonatal Care · doi:10.1097/anc.0000000000000600 · Cited by 20
Cardiovascular drugs and erectile dysfunction – a symmetry analysis
Rasmussen, L., Hallas, J., Madsen, K. G., & Pottegård, A. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12696 · Cited by 19
Quinn, A. L., Dean, O. M., Davey, C. G., Kerr, M., Harrigan, S., Cotton, S., Chanen, A. M., Dodd, S., Ratheesh, A., Amminger, G. P., et al. (2015) · Early Intervention in Psychiatry · doi:10.1111/eip.12280 · Cited by 20
Hutton, J. L. (2010) · Pharmaceutical Medicine · doi:10.1007/bf03256810 · Cited by 19
Bria, E., Ciccarese, M., Giannarelli, D., Cuppone, F., Nisticò, C., Nuzzo, C. M. A., Natoli, G., Fabi, A., Terzoli, E., Cognetti, F., et al. (2006) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2006.04.009 · Cited by 19
Martínez‐Vizcaíno, V., Díez‐Fernández, A., Álvarez‐Bueno, C., Alfonso, J. M., & Cavero‐Redondo, I. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10122713 · Cited by 19
Corrao, G., Franchi, M., Cereda, D., Bortolan, F., Leoni, O., Vignati, E., Pavesi, G., & Gori, A. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07823-3 · Cited by 19
Antibiotics for secondary prevention of coronary heart disease
Sethi, N. J., Safi, S., Korang, S. K., Hróbjartsson, A., Skoog, M., Gluud, C. N., & Jakobsen, J. C. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003610.pub3 · Cited by 19
Metadata
- Authors
- Altman, D. G.
- Corresponding author
- Altman, Douglas G
- ORCID
- Altman, Douglas G
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 1998-11-07
- Volume
- 317
- Issue
- 7168
- Pages
- 1309-1312
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- PMC
- PMC1114210
- OpenAlex
- W1982900907
- Cited by
- 938
- References
- 14
- Citations by year
- 2026: 29 · 2025: 16 · 2024: 33 · 2023: 30 · 2022: 36 · 2021: 36 · 2020: 32 · 2019: 39 · 2018: 29 · 2017: 30 · 2016: 39 · 2015: 32 · 2014: 43 · 2013: 29 · 2012: 32
- FWCI
- 19.72
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.bmj.com/company/legal-information/terms-conditions/legal-information/tdm-licencepolicy (tdm)
- Locations
- BMJ (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Epidemiology
- Keywords
- atrial fibrillation, chronic obstructive pulmonary disease, lung function, FEV1, cardiac arrhythmias, risk prediction, Copenhagen City Heart Study
- MeSH terms
- Confidence Intervals, Randomized Controlled Trials as Topic, Sample Size, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review